Related by context. Frequent words. (Click for all words.) 74 proteasome inhibitor 72 Daclizumab 72 ONX 71 Nexavar ® 71 Initiates Phase II 71 refractory chronic lymphocytic 70 ALN TTR 70 MKC# 70 phenylalanine ammonia lyase 70 polymerase inhibitor 70 PEG PAL PEGylated recombinant 69 Voreloxin 69 Panzem R 69 Ofatumumab 69 OncoVEX GM CSF 68 CYC# 68 Drug Candidate 68 R sorafenib tablets 68 multi kinase inhibitor 68 Tesetaxel 68 liposomal formulation 68 AEG# 68 Carfilzomib 68 humanized anti 68 Onalta 68 Copegus R 68 NEBIDO R 67 Bavituximab 67 R bortezomib 67 PEG SN# 67 polymerase inhibitors 67 Racivir 67 Pivotal Phase III 67 HCV protease inhibitor 67 Bortezomib 67 Epratuzumab 67 inhaled formulation 67 TELINTRA 67 Perifosine 67 Boceprevir 67 Dapagliflozin 67 Mipomersen 67 CCX# 67 Belimumab 67 Commences Phase 67 Clevudine 67 Presents Positive 67 drug conjugate 67 forodesine 67 MEK inhibitor 66 novel oral tubulin 66 TLR9 agonist 66 JAK1 66 SAR# [004] 66 Initiate Phase 66 EZN 66 Metastatic Melanoma 66 anticancer compound 66 Thiarabine 66 Advancing Drugs 66 Pivotal Phase 66 Preclinical Data 66 Phase III Clinical Trial 66 Pegasys ® 66 relapsed multiple myeloma 66 Traficet EN 66 phase IIb clinical 66 fibrosis IPF 66 novel orally administered 66 ALN TTR# 65 CD# antibody [001] 65 Factor VIIa 65 Phase Ib II 65 hepatitis C HCV 65 topical anti infective 65 targeting CD# 65 vascular disrupting agent 65 Patient Enrollment 65 developing Zerenex TM 65 cancer immunotherapies 65 proteasome inhibitors 65 BY JIM HAND 65 Amrubicin 65 thymalfasin 65 Dasatinib 65 Medarex logo 65 Vandetanib 65 Nanobody 65 orally bioavailable 65 Initiates Phase 65 Completes Enrollment 65 Clinical Trial Results 65 BY DAVID LINTON 65 elotuzumab 65 mTOR inhibitor 65 Lenalidomide 65 ANYARA 65 MVA BN R 65 Tamibarotene 65 Ambrisentan 64 Elesclomol